83 FR 18314 - Establishment of the National Clinical Care Commission and Solicitation of Nominations for Commission Members

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 81 (April 26, 2018)

Page Range		18314-18316
FR Document		2018-08797

The U.S. Department of Health and Human Services (HHS) hereby announces the establishment of the National Clinical Care Commission (the Commission) pursuant to the National Clinical Care Commission Act. The Commission will consist of representatives of specific federal agencies and non-federal individuals and entities who represent diverse disciplines and views. The Commission will evaluate and make recommendations to the HHS Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases. Through this notice, HHS is also requesting nominations of individuals who are interested in being considered for appointment to the Commission. Resumes or curricula vitae from qualified individuals who wish to be considered for appointment as a member of the Commission are currently being accepted.

Federal Register, Volume 83 Issue 81 (Thursday, April 26, 2018)

[Federal Register Volume 83, Number 81 (Thursday, April 26, 2018)]
[Notices]
[Pages 18314-18316]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2018-08797]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Establishment of the National Clinical Care Commission and
Solicitation of Nominations for Commission Members

AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, U.S.
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Health and Human Services (HHS) hereby
announces the establishment of the National Clinical Care Commission
(the Commission) pursuant to the National Clinical Care Commission Act.
The Commission will consist of representatives of specific federal
agencies and non-federal individuals and entities who represent diverse
disciplines and views. The Commission will evaluate and make
recommendations to the HHS Secretary and Congress regarding
improvements to the coordination and leveraging of federal programs
related to awareness and clinical care for complex metabolic or
autoimmune diseases that result from issues related to insulin that
represent a significant disease burden in the United States, which may
include complications due to such diseases.
Through this notice, HHS is also requesting nominations of
individuals who are interested in being considered for appointment to
the Commission. Resumes or curricula vitae from qualified individuals
who wish to be considered for appointment as a member of the Commission
are currently being accepted.

DATES: Nominations must be received no later than close of business May
29, 2018.

ADDRESSES: Qualified persons and interested organizations are invited
to

[[Page 18315]]

submit nominations by any of the following methods:
Email: OHQ@hhs.gov (please indicate in the subject line:
National Clinical Care Commission)
Mail/Courier: Office of Disease Prevention and Health
Promotion, Attn: Division of Health Care Quality, Department of Health
and Human Services, 1101 Wootton Parkway, Suite LL100, Rockville, MD
20852.

FOR FURTHER INFORMATION CONTACT: Clydette Powell, MD, MPH, FAAP,
Director, Division of Health Care Quality, Office of Disease Prevention
and Health Promotion, Office of the Assistant Secretary for Health;
U.S. Department of Health and Human Services; Telephone: 240-453-8239;
Email address: OHQ@hhs.gov (please indicate in the subject line:
National Clinical Care Commission). The Commission charter may be
accessed online at https://health.gov/hcq/national-clinical-care-commission.asp. The charter includes detailed information about the
purpose, function, and structure of the Commission.

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act
(Pub. L. 115-80) requires the HHS Secretary to establish the National
Clinical Care Commission. The Commission will consist of
representatives of specific federal agencies and non-federal
individuals and entities who represent diverse disciplines and views.
The Commission will evaluate and make recommendations to the HHS
Secretary and Congress regarding improvements to the coordination and
leveraging of federal programs related to awareness and clinical care
for complex metabolic or autoimmune diseases that result from issues
related to insulin that represent a significant disease burden in the
United States, which may include complications due to such diseases.
Objectives and Scope of Activities. The Commission shall evaluate
and make recommendations, as appropriate, to the Secretary and Congress
regarding:
(1) Federal programs of the Department of Health and Human Services
that focus on preventing and reducing the incidence of complex
metabolic or autoimmune diseases resulting from issues related to
insulin that represent a significant disease burden in the United
States, which may include complications due to such diseases;
(2) Current activities and gaps in federal efforts to support
clinicians in providing integrated, high-quality care to individuals
with the diseases and complications;
(3) The improvement in, and improved coordination of, federal
education and awareness activities related to the prevention and
treatment of the diseases and complications, which may include the
utilization of new and existing technologies;
(4) Methods for outreach and dissemination of education and
awareness materials that--
(a) address the diseases and complications;
(b) are funded by the federal government; and
(c) are intended for health care professionals and the public; and
(5) Whether there are opportunities for consolidation of
inappropriately overlapping or duplicative federal programs related to
the diseases and complications.
Membership and Designation. The Commission shall consist of 23
voting members. The composition shall include eleven ex-officio members
and twelve non-federal members. The ex-officio members shall consist of
the heads of, or subordinate officials designated by the heads of, the
following federal departments, agencies, or components: The Centers for
Medicare and Medicaid Services, the Agency for Healthcare Research and
Quality, the Centers for Disease Control and Prevention, the Indian
Health Service, the National Institutes of Health, the Food and Drug
Administration, the Health Resources and Services Administration, the
Office of Minority Health, the Department of Defense, the Department of
Veterans Affairs, and the Department of Agriculture.
The twelve non-federal members shall be appointed as special
government employees (SGEs) by the Secretary and shall have expertise
in prevention, care, and epidemiology of any of the diseases and
complications described in Section 2(a) of the National Clinical Care
Commission Act. The non-federal members shall include one or more
members from each of the following categories: Physician specialties,
including clinical endocrinologists, that play a role in the prevention
or treatment of diseases and complications; primary care physicians;
non-physician health care professionals; patient advocates; national
experts, including public health experts; and health care providers
furnishing services to a patient population that consists of a high
percentage (as specified by the Secretary) of individuals who are
enrolled in a state plan under title XIX of the Social Security Act or
who are not covered under a health plan or health insurance coverage.
One of the non-federal members shall be selected by the members to
serve as the Chair.
The ex-officio members and non-federal members shall be appointed
to serve for the duration of the time that the Commission is authorized
to operate. Any vacancy of a non-federal member shall be filled in the
same manner as the original appointments. Any non-federal member who is
appointed to fill the vacancy of an unexpired term shall be appointed
to serve for the remainder of that term.
Pursuant to advance written agreement, each non-federal member of
the Commission will waive his or her right to compensation for
performing services as a member of the Commission. However, non-federal
members shall receive per diem and reimbursement for travel expenses
incurred in relation to performing duties for the Commission, as
authorized by FACA and 5 U.S.C. 5703 for persons who are employed
intermittently to perform services for the Federal government and in
accordance with federal travel regulations. Ex-officio members of the
Commission remain covered under their current compensation system.
Estimated Number and Frequency of Meetings. The Commission shall
meet at least twice and not more than four times a year. These meetings
may be in person or conducted by teleconference or videoconference at
the discretion of the Designated Federal Official (DFO). The meetings
shall be open to the public, except as determined otherwise by the
Secretary, or other official to whom authority has been delegated, in
accordance with the guidelines under Government in the Sunshine Act, 5
U.S.C. 552b(c). Notice of all meetings shall be provided to the public
in accordance with the FACA. Meetings shall be conducted and records of
the proceedings shall be kept, as required by applicable laws and
departmental policies. A quorum is required for the Commission to meet
to conduct business. A quorum shall consist of a majority of the
Commission's voting members.
When the Secretary or designee determines that a meeting shall be
closed or partially closed to the public, in accordance with
stipulations of Government in the Sunshine Act, 5 U.S.C. 552b(c), then
a report shall be prepared by the DFO that includes, at a minimum, a
list of members and their business addresses, the Commission's
functions, date and place of the meeting, and a summary of the
Commission's activities and recommendations made

[[Page 18316]]

during the fiscal year. A copy of the report will be provided to the
Department's Committee Management Officer.
Nominations. Nominations, including self-nominations, of
individuals who have the specified expertise and knowledge will be
considered for appointment as members of the Commission. A nomination
should include, at a minimum, the following for each nominee: (1) A
letter of nomination that clearly states the name and affiliation of
the nominee, the basis for the nomination, and a statement from the
nominee that indicates that the individual is willing to serve as a
member of the Commission, if selected; (2) a one-page biography that
describes the nominee's qualifications and, if applicable, highlights
relevant experience on other federal advisory committees; (3) the
nominator's name, address, and daytime telephone number; and the
address, telephone number, and email address of the individual being
nominated; and (4) a current copy of the nominee's curriculum vitae or
resume, which should be limited to no more than 30 pages. Incomplete
nomination packages will not be reviewed.
Every effort will be made to ensure that the composition of the
Commission includes individuals from various geographic locations,
including rural and underserved areas; racial and ethnic minorities;
genders, and persons living with disabilities. Individuals other than
officers or employees of the United States government being considered
for appointment as members of the Commission will be required to
complete and submit a report of their financial holdings. An ethics
review must be conducted to ensure that individuals appointed as
members of the Commission are not involved in any activity that may
pose a potential conflict of interest for the official duties that are
to be performed. This is a federal ethics requirement that must be
satisfied upon entering the position and annually throughout the
established term of appointment on the Commission.

Authority: The National Clinical Care Commission Act (Pub. L.
115-80) requires establishment of the National Clinical Care
Commission. The Commission is governed by provisions of the Federal
Advisory Committee Act, Public Law 92-463, as amended (5 U.S.C.
App.), which sets forth standards for the formation and use of
federal advisory committees.

Dated: April 19, 2018.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health
Promotion).
[FR Doc. 2018-08797 Filed 4-25-18; 8:45 am]
BILLING CODE 4150-32-P

18316 Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices

during the fiscal year. A copy of the Dated: April 19, 2018. FOR FURTHER INFORMATION CONTACT:
report will be provided to the Don Wright, Jomana Musmar, Acting Designated
Department’s Committee Management Deputy Assistant Secretary for Health Federal Officer, Presidential Advisory
Officer. (Disease Prevention and Health Promotion). Council on Combating Antibiotic-
Nominations. Nominations, including [FR Doc. 2018–08797 Filed 4–25–18; 8:45 am] Resistant Bacteria, Office of the
BILLING CODE 4150–32–P Assistant Secretary for Health, U.S.
self-nominations, of individuals who
Department of Health and Human
have the specified expertise and
Services, Room 715H, Hubert H.
knowledge will be considered for Humphrey Building, 200 Independence
DEPARTMENT OF HEALTH AND
appointment as members of the HUMAN SERVICES Avenue, SW, Washington, DC 20201.
Commission. A nomination should Phone: (202) 690–5566; email: CARB@
include, at a minimum, the following Meeting of the Presidential Advisory hhs.gov.
for each nominee: (1) A letter of Council on Combating Antibiotic-
nomination that clearly states the name SUPPLEMENTARY INFORMATION: Under
Resistant Bacteria
and affiliation of the nominee, the basis Executive Order 13676, dated
AGENCY: Office of the Assistant September 18, 2014, authority was given
for the nomination, and a statement
Secretary for Health, Office of the to the Secretary of HHS to establish the
from the nominee that indicates that the
Secretary, Department of Health and Advisory Council, in consultation with
individual is willing to serve as a the Secretaries of Defense and
member of the Commission, if selected; Human Services.
ACTION: Notice.
Agriculture. Activities of the Advisory
(2) a one-page biography that describes Council are governed by the provisions
the nominee’s qualifications and, if of Public Law 92–463, as amended (5
SUMMARY: As stipulated by the Federal
applicable, highlights relevant U.S.C. App.), which sets forth standards
Advisory Committee Act, the
experience on other federal advisory for the formation and use of federal
Department of Health and Human
committees; (3) the nominator’s name, Services (HHS) is hereby giving notice advisory committees.
address, and daytime telephone that a meeting is scheduled to be held The Advisory Council will provide
number; and the address, telephone for the Presidential Advisory Council on advice, information, and
number, and email address of the Combating Antibiotic-Resistant Bacteria recommendations to the Secretary of
individual being nominated; and (4) a (Advisory Council). The meeting will be HHS regarding programs and policies
current copy of the nominee’s open to the public; a public comment intended to support and evaluate the
curriculum vitae or resume, which session will be held during the meeting. implementation of Executive Order
should be limited to no more than 30 Pre-registration is required for members 13676, including the National Strategy
pages. Incomplete nomination packages of the public who wish to attend the for Combating Antibiotic-Resistant
will not be reviewed. meeting and who wish to participate in Bacteria and the National Action Plan
the public comment session. Individuals for Combating Antibiotic-Resistant
Every effort will be made to ensure
who wish to attend the meeting and/or Bacteria. The Advisory Council shall
that the composition of the Commission function solely for advisory purposes.
includes individuals from various send in their public comment via email
should send an email to CARB@hhs.gov. In carrying out its mission, the
geographic locations, including rural Advisory Council will provide advice,
and underserved areas; racial and ethnic Registration information is available on
the website http://www.hhs.gov/ash/ information, and recommendations to
minorities; genders, and persons living the Secretary regarding programs and
carb/ and must be completed by May 9,
with disabilities. Individuals other than policies intended to preserve the
2018; all in-person attendees must pre-
officers or employees of the United effectiveness of antibiotics by
register by this date. Additional
States government being considered for information about registering for the optimizing their use; advance research
appointment as members of the meeting and providing public comment to develop improved methods for
Commission will be required to can be obtained at http://www.hhs.gov/ combating antibiotic resistance and
complete and submit a report of their ash/carb/ on the Meetings page. conducting antibiotic stewardship;
financial holdings. An ethics review strengthen surveillance of antibiotic-
DATES: The meeting is scheduled to be
must be conducted to ensure that resistant bacterial infections; prevent
held on May 16, 2018, from 9:00 a.m. to the transmission of antibiotic-resistant
individuals appointed as members of
4:45 p.m. ET (times are tentative and bacterial infections; advance the
the Commission are not involved in any subject to change). The confirmed times
activity that may pose a potential development of rapid point-of-care and
and agenda items for the meeting will be agricultural diagnostics; further research
conflict of interest for the official duties posted on the website for the Advisory
that are to be performed. This is a on new treatments for bacterial
Council at http://www.hhs.gov/ash/ infections; develop alternatives to
federal ethics requirement that must be carb/ when this information becomes
satisfied upon entering the position and antibiotics for agricultural purposes;
available. Pre-registration for attending maximize the dissemination of up-to-
annually throughout the established the meeting in person is required to be date information on the appropriate and
term of appointment on the completed no later than May 9, 2018; proper use of antibiotics to the general
Commission. public attendance at the meeting is public and human and animal
Authority: The National Clinical Care limited to the available space. healthcare providers; and improve
Commission Act (Pub. L. 115–80) requires ADDRESSES: U.S. Department of Health international coordination of efforts to
amozie on DSK30RV082PROD with NOTICES

establishment of the National Clinical Care and Human Services, Hubert H. combat antibiotic resistance.
Commission. The Commission is governed by Humphrey Building, Great Hall, 200 The May 16, 2018, public meeting
provisions of the Federal Advisory Independence Avenue SW, Washington, will be focused on the topic of antibiotic
Committee Act, Public Law 92–463, as DC 20201. stewardship for animal and plant
amended (5 U.S.C. App.), which sets forth The meeting can also be accessed health. The meeting agenda will be
standards for the formation and use of federal through a live webcast on the day of the posted on the Advisory Council website
advisory committees. meeting. For more information, at http://www.hhs.gov/ash/carb/ when it

VerDate Sep<11>2014 16:58 Apr 25, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\26APN1.SGM 26APN1

Document Created: 2018-11-02 08:19:44
Document Modified: 2018-11-02 08:19:44

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Nominations must be received no later than close of business May 29, 2018.
Contact		Clydette Powell, MD, MPH, FAAP, Director, Division of Health Care Quality, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health; U.S. Department of Health and Human Services; Telephone: 240-453-8239;
FR Citation		83 FR 18314